Anzeige
Mehr »
Login
Dienstag, 28.01.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PSNF ISIN: US6300873022 Ticker-Symbol: NV3P 
Tradegate
28.01.20
14:45 Uhr
11,100 Euro
-3,400
-23,45 %
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NANOVIRICIDES INC Chart 1 Jahr
5-Tage-Chart
NANOVIRICIDES INC 5-Tage-Chart
RealtimeGeldBriefZeit
11,000
11,400
15:07

Aktuelle News zur NANOVIRICIDES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoNANOVIRICIDES, INC. - 8-K, Current Report13
NANOVIRICIDES Aktie jetzt für 4€ handeln
MoNanoViricides legt 475% in nur 5 Tage zu - was nun?1.020Pullback Trading-Strategie Symbol: NNVC ISIN: US6300872032 Rückblick: Der Ausbruch des tödlichen Coronavirus löst große Bewegungen bei den Biotechnologieaktien aus. Dieser Sektor zählt generell...
► Artikel lesen
MoMid-Day Market Update: Dow Falls 1.5%; NanoViricides Shares Spike Higher2
SaNanoViricides, Inc.: NanoViricides Closes on $8.625 Million Underwritten Public Offering of Common Stock1.422SHELTON, CONNECTICUT / ACCESSWIRE / January 24, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a...
► Artikel lesen
DoNanoViricides among healthcare gainers; Tetraphase Pharmaceuticals leads the losers16
MiNanoViricides: Darum sind Coronavirus-Zocks so gefährlich!1.893Bereits gestern schrieb ich hier auf sharedeals.de einen Artikel über die Aktie von Novavax, die aufgrund des in China beziehungsweise Asien grassierenden Coronavirus durch die Decke ging. Ein weiterer...
► Artikel lesen
MiBaudax Bio and Neurotrope among healthcare gainers; NanoViricides leads the losers6
MiNanoViricides prices equity offering; shares down 56% premarket12
MiNanoViricides, Inc.: NanoViricides Prices $7.5 Million Underwritten Public Offering of Common Stock1.282SHELTON, CT / ACCESSWIRE / January 21, 2020 / NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines...
► Artikel lesen
21.01.Nanoviricides rallies 113% on China virus13
09.01.NanoViricides up 7% premarket on advancement of shingles candidate2
09.01.NanoViricides, Inc.: NanoViricides Successfully Completes Required Genetic Toxicology Testing of Lead Drug Candidate NV-HHV-1011.223SHELTON, CT / ACCESSWIRE / January 9, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a company with novel platform technology to treat difficult and life-threatening viral diseases...
► Artikel lesen
07.01.NanoViricides, Inc.: NanoViricides Has Initiated Genetic Toxicology Testing Required for an IND for Its Drug Candidate1.201SHELTON, CT / ACCESSWIRE / January 7, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company") a company with novel platform technology to treat difficult and life-threatening viral diseases, announces...
► Artikel lesen
07.01.NANOVIRICIDES, INC. - S-1/A, General form for registration of securities1
06.01.NanoViricides up 22% premarket on cash infusion1
06.01.NanoViricides, Inc.: NanoViricides Receives Cash Infusion of $2.25 Million1.234SHELTON, CT / ACCESSWIRE / January 6, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in nanomedicines against viruses, reports that it has received a cash infusion...
► Artikel lesen
23.12.19NANOVIRICIDES, INC. - S-1/A, General form for registration of securities-
19.12.19NANOVIRICIDES, INC. - 8-K, Current Report-
17.12.19NanoViricides, Inc.: NanoViricides Inc.: Upcoming Human Clinical Trials Create Opportunity for Innovation1.459The Company's innovative new drug is heading to Human Clinical Trials SHELTON, CT / ACCESSWIRE / December 17, 2019 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), is a development stage...
► Artikel lesen
13.12.19NANOVIRICIDES, INC. - 8-K, Current Report-
Seite:  Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1